nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Nephrotoxicity—Teniposide—lymphatic system cancer	0.058	0.058	CcSEcCtD
Colistimethate—Nephrotoxicity—Carmustine—lymphatic system cancer	0.0326	0.0326	CcSEcCtD
Colistimethate—Nephropathy toxic—Teniposide—lymphatic system cancer	0.0321	0.0321	CcSEcCtD
Colistimethate—Rales—Bleomycin—lymphatic system cancer	0.029	0.029	CcSEcCtD
Colistimethate—Oliguria—Mechlorethamine—lymphatic system cancer	0.0272	0.0272	CcSEcCtD
Colistimethate—Respiratory distress—Fludarabine—lymphatic system cancer	0.0255	0.0255	CcSEcCtD
Colistimethate—Haemoptysis—Fludarabine—lymphatic system cancer	0.0219	0.0219	CcSEcCtD
Colistimethate—Nephropathy toxic—Bleomycin—lymphatic system cancer	0.0207	0.0207	CcSEcCtD
Colistimethate—Proteinuria—Fludarabine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Colistimethate—Protein urine present—Fludarabine—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Colistimethate—Nephropathy toxic—Carmustine—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Colistimethate—Nephropathy toxic—Mitoxantrone—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Colistimethate—Respiratory distress—Vincristine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Colistimethate—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Colistimethate—Rales—Methotrexate—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Colistimethate—Wheezing—Bleomycin—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Colistimethate—Bronchospasm—Teniposide—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Colistimethate—Proteinuria—Mitoxantrone—lymphatic system cancer	0.011	0.011	CcSEcCtD
Colistimethate—Protein urine present—Mitoxantrone—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Colistimethate—Candida infection—Carmustine—lymphatic system cancer	0.00991	0.00991	CcSEcCtD
Colistimethate—Vertigo—Mechlorethamine—lymphatic system cancer	0.00983	0.00983	CcSEcCtD
Colistimethate—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.00911	0.00911	CcSEcCtD
Colistimethate—Epistaxis—Fludarabine—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Colistimethate—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Colistimethate—Bronchospasm—Bleomycin—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Colistimethate—Malnutrition—Fludarabine—lymphatic system cancer	0.00709	0.00709	CcSEcCtD
Colistimethate—Chest pain—Teniposide—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Colistimethate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Colistimethate—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Colistimethate—Cough—Fludarabine—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Colistimethate—Convulsion—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Colistimethate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Colistimethate—Arthralgia—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Colistimethate—Dyspnoea—Teniposide—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Colistimethate—Decreased appetite—Teniposide—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Colistimethate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Colistimethate—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Colistimethate—Apnoea—Methotrexate—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Colistimethate—Rash—Mechlorethamine—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Colistimethate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Colistimethate—Proteinuria—Methotrexate—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Colistimethate—Protein urine present—Methotrexate—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Colistimethate—Nausea—Mechlorethamine—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Colistimethate—Urticaria—Teniposide—lymphatic system cancer	0.00523	0.00523	CcSEcCtD
Colistimethate—Oliguria—Methotrexate—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Colistimethate—Body temperature increased—Teniposide—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Colistimethate—Paraesthesia—Fludarabine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Colistimethate—Dyspnoea—Fludarabine—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Colistimethate—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Colistimethate—Dysarthria—Methotrexate—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Colistimethate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Colistimethate—Fatigue—Fludarabine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Colistimethate—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Colistimethate—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Colistimethate—Urethral disorder—Vincristine—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Colistimethate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Colistimethate—Asthenia—Teniposide—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Colistimethate—Body temperature increased—Fludarabine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Colistimethate—Mental disorder—Carmustine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Colistimethate—Malnutrition—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Colistimethate—Cough—Bleomycin—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Colistimethate—Diarrhoea—Teniposide—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Colistimethate—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Colistimethate—Chest pain—Bleomycin—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Colistimethate—Mental disorder—Vincristine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Colistimethate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Colistimethate—Vomiting—Teniposide—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Colistimethate—Asthenia—Fludarabine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Colistimethate—Rash—Teniposide—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Colistimethate—Dermatitis—Teniposide—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Colistimethate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Colistimethate—Headache—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Colistimethate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Colistimethate—Convulsion—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Colistimethate—Nausea—Teniposide—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Colistimethate—Vertigo—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Colistimethate—Chest pain—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Colistimethate—Anxiety—Carmustine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Colistimethate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Colistimethate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Colistimethate—Convulsion—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Colistimethate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Colistimethate—Cough—Mitoxantrone—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Colistimethate—Vomiting—Fludarabine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Colistimethate—Convulsion—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Colistimethate—Rash—Fludarabine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Colistimethate—Dermatitis—Fludarabine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Colistimethate—Headache—Fludarabine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Colistimethate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Colistimethate—Chest pain—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Colistimethate—Anxiety—Mitoxantrone—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Colistimethate—Nervous system disorder—Vincristine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Colistimethate—Nausea—Fludarabine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Colistimethate—Urticaria—Bleomycin—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Colistimethate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Colistimethate—Paraesthesia—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Colistimethate—Dyspnoea—Carmustine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Colistimethate—Somnolence—Carmustine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Decreased appetite—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Colistimethate—Paraesthesia—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Colistimethate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Colistimethate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Colistimethate—Decreased appetite—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Colistimethate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Colistimethate—Somnolence—Mitoxantrone—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Colistimethate—Fatigue—Vincristine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Colistimethate—Asthenia—Bleomycin—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Colistimethate—Asthma—Methotrexate—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Colistimethate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Colistimethate—Fatigue—Mitoxantrone—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Colistimethate—Body temperature increased—Carmustine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Colistimethate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Colistimethate—Body temperature increased—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Colistimethate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Colistimethate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Colistimethate—Vomiting—Bleomycin—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Colistimethate—Rash—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Colistimethate—Dermatitis—Bleomycin—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Colistimethate—Asthenia—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Colistimethate—Hypersensitivity—Vincristine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Colistimethate—Epistaxis—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Asthenia—Vincristine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Diarrhoea—Carmustine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Colistimethate—Nausea—Bleomycin—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Colistimethate—Asthenia—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Colistimethate—Dizziness—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Colistimethate—Diarrhoea—Vincristine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Colistimethate—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Colistimethate—Urethral disorder—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Colistimethate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Vomiting—Carmustine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Colistimethate—Dizziness—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Rash—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Dermatitis—Carmustine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Colistimethate—Headache—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Colistimethate—Tinnitus—Methotrexate—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Colistimethate—Vomiting—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Colistimethate—Rash—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Colistimethate—Dermatitis—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Colistimethate—Headache—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Colistimethate—Nausea—Carmustine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Colistimethate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Colistimethate—Immune system disorder—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Colistimethate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Colistimethate—Rash—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Colistimethate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Colistimethate—Headache—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Colistimethate—Mental disorder—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Colistimethate—Malnutrition—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Colistimethate—Nausea—Vincristine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Colistimethate—Dysgeusia—Methotrexate—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Colistimethate—Nausea—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Colistimethate—Vertigo—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Colistimethate—Cough—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Colistimethate—Convulsion—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Colistimethate—Chest pain—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Colistimethate—Arthralgia—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Colistimethate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Colistimethate—Paraesthesia—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Colistimethate—Dyspnoea—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Colistimethate—Somnolence—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Colistimethate—Decreased appetite—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Fatigue—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Urticaria—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Body temperature increased—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Asthenia—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Colistimethate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Colistimethate—Dizziness—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Colistimethate—Vomiting—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Colistimethate—Rash—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Dermatitis—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Headache—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Nausea—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
